InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Nash Huw M., Chief Operating Officer. Insider active across 1 company, notably Stoke Therapeutics, Inc.. Cumulatively, 12 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €30k. History available since 1 June 2021. The latest transaction was disclosed on 2 July 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Nash Huw M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
2,467 shares@ US$13.10114.7% of flowCommon StockSEC:0001415889-24-019169:0
50,000 shares@ US$0.409.0% of flowCommon StockSEC:0001415889-24-014093:0
50,000 shares@ US$0.409.1% of flowCommon StockSEC:0001415889-24-009993:0
13,100 shares0Common StockSEC:0001415889-24-008686:0
3,800 shares@ US$2.195.4% of flowCommon StockSEC:0001209191-22-001849:0
5,700 shares@ US$2.198.1% of flowCommon StockSEC:0001209191-21-067950:0
3,800 shares@ US$2.195.3% of flowCommon StockSEC:0001209191-21-062772:0
5,700 shares@ US$2.197.9% of flowCommon StockSEC:0001209191-21-059111:0
5,700 shares@ US$2.197.7% of flowCommon StockSEC:0001209191-21-054552:0
5,700 shares@ US$2.197.7% of flowCommon StockSEC:0001209191-21-049793:0
5,700 shares@ US$2.197.7% of flowCommon StockSEC:0001209191-21-045097:0
575 shares@ US$2.190.8% of flowCommon StockSEC:0001209191-21-037839:0
12 of 12 declarations
About Nash Huw M.
Nash Huw M. is Chief Operating Officer and Chief Commercial Officer. He has 12 filings in total, and among the sampled recent filings from 2021-06-03 to 2024-07-03, sales total EUR 30070 and the most frequent transaction type is Option exercise. His filings concern Stoke Therapeutics, Inc., where he is Chief Business Officer.
